Claude Preudhomme
- Hematology top 0.02%
- Acute Myeloid Leukemia Research 215
- Chronic Myeloid Leukemia Treatments 84
- Multiple Myeloma Research and Treatments 30
- Genetics top 0.05%
- Chronic Lymphocytic Leukemia Research 74
- Myeloproliferative Neoplasms: Diagnosis and Treatment 47
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 36
- Oncology top 1%
- Molecular Biology top 1%
-
- Acute Lymphoblastic Leukemia research 67
-
- Lymphoma Diagnosis and Treatment 38
- Co-authors
- Pierre FenauxBruno QuesnelF BautersChristophe RoumierAline RennevilleEric WattelHervé DombretNicolas Boissel
- Cited by
- HematologyGeneticsCancer Research
- Journals
- Nature Medicine (1 paper)Nature Communications (1 paper)Journal of Clinical Oncology (9 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Claude Preudhomme
342 papers receiving 13.0k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Hematology 9.4k
- Genetics 4.4k
- Cancer Research 1.4k
- Oncology 2.4k
- Molecular Biology 5.7k
Countries citing papers authored by Claude Preudhomme
This map shows the geographic impact of Claude Preudhomme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Preudhomme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Preudhomme more than expected).
Fields of papers citing papers by Claude Preudhomme
This network shows the impact of papers produced by Claude Preudhomme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Preudhomme. The network helps show where Claude Preudhomme may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Claude Preudhomme, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 5 | |
| 5 | 2021 | 25 | |
| 6 | 2020 | 10 | |
| 7 | 2020 | 8 | |
| 8 | 2019 | 29 | |
| 9 | 2018 | 3 | |
| 10 | 2017 | 62 | |
| 11 | 2017 | 61 | |
| 12 | 2017 | 1 | |
| 13 | 2017 | 3 | |
| 14 | 2015 | 82 | |
| 15 | 2007 | 1 | |
| 16 | 2006 | 3 | |
| 17 | 2004 | 2 | |
| 18 | Stratégies thérapeutiques et recommandations pour la prise en charge des patients atteints de leucémie myéloïde chronique | 2003 | 2 |
| 19 | Délétion chromosomique 17p, mutation de P53, anomalie de Pelger-Huët et vacuolisation des granulocytes : une nouvelle entité dans les pathologies myéloïdes ? | 1995 | 1 |
| 20 | Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis. | 1992 | 122 |
About Claude Preudhomme
Claude Preudhomme is a scholar working on Hematology, Genetics and Cancer Research, having authored 356 papers that have together received 13.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (215 papers), Chronic Myeloid Leukemia Treatments (84 papers), Chronic Lymphocytic Leukemia Research (74 papers), Acute Lymphoblastic Leukemia research (67 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (47 papers), Lymphoma Diagnosis and Treatment (38 papers), Cancer Genomics and Diagnostics (36 papers) and Multiple Myeloma Research and Treatments (30 papers). The work is most often cited by research in Hematology (9.4k citations), Genetics (4.4k citations) and Cancer Research (1.4k citations). Claude Preudhomme has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Pierre Fenaux, Bruno Quesnel, F Bauters, Christophe Roumier, Aline Renneville, Eric Wattel, Hervé Dombret, Nicolas Boissel, Catherine Roche‐Lestienne and Valérie Soenen. Their work appears in journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.